Company News: Johnson & Johnson (JNJ) Q3 results beat analysts’ expectations

Market news

16 October 2018

Company News: Johnson & Johnson (JNJ) Q3 results beat analysts’ expectations

Johnson & Johnson (JNJ) reported Q3 FY 2018 earnings of $2.05 per share (versus $1.90 in Q3 FY 2017), beating analysts' consensus estimate of $2.03.

The company's quarterly revenues amounted to $20.348 bln (+3.6% y/y), beating analysts' consensus estimate of $20.053 bln.

The company also raised guidance for FY 2018, projecting EPS of $8.13-8.18 (versus analysts' consensus estimate of $8.15 and compared to $8.07-8.17 prior) and revenues of $81.0-81.4 bln (versus analysts' consensus estimate of $81.26 bln and compared to $80.5-81.3 bln prior).

JNJ rose to $134.00 (+0.04%) in pre-market trading.

Company News: Morgan Stanley (MS) Q3 results beat analysts’ forecasts

Pastor Arrives Back in U.S. After Two Years of Detainment in Turkey

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.